Gut Microbiome Linked to Worse Outcomes for Fatty Liver Disease Patients with Foodborne Infections

UC Irvine study finds gut dysbiosis in metabolic dysfunction-associated fatty liver disease increases severity of Vibrio vulnificus infections.

Apr. 16, 2026 at 5:38am

Got story updates? Submit your updates here. ›

An extreme close-up, translucent X-ray image revealing the internal structures of a diseased liver, with signs of inflammation, damage, and fibrosis, conceptually illustrating the severe impact of gut microbiome dysfunction on infection outcomes for patients with fatty liver disease.An X-ray view into the damaged liver of a patient with fatty liver disease, highlighting the severe impact of gut microbiome dysfunction on infection outcomes.Irvine Today

Researchers at the University of California, Irvine's Joe C. Wen School of Population & Public Health have discovered that changes in the gut microbiome of individuals with metabolic dysfunction-associated steatotic liver disease (MASLD), or fatty liver disease, can significantly worsen outcomes from certain foodborne infections. The study, published in the journal Gut Microbes, found that MASLD mice exhibited far greater liver damage, inflammation, and fibrosis compared to healthy mice after exposure to the potentially life-threatening bacteria Vibrio vulnificus.

Why it matters

MASLD is a growing global health concern, affecting millions worldwide, and patients with the condition are already known to face higher risks of severe infections. This study provides critical insight into the biological mechanisms driving this increased vulnerability, identifying the gut microbiome as a central player. The findings lay the groundwork for future strategies focused on prevention, risk reduction, and microbiome-based interventions to better protect high-risk populations as cases of foodborne illnesses continue to rise.

The details

The researchers found that MASLD disrupts normal gut function, leading to increased intestinal permeability, altered immune responses, and microbial imbalance - collectively known as gut dysbiosis. These changes allow harmful bacteria and inflammatory signals to more easily travel from the gut to the liver through the gut-liver axis. As a result, MASLD mice exposed to Vibrio vulnificus experienced significantly more severe outcomes, including elevated markers of liver injury, increased levels of iron-related proteins that can fuel bacterial growth, heightened activation of pro-inflammatory immune cells, and faster progression to liver scarring and early cirrhotic changes. In contrast, healthy mice exposed to the same pathogen showed far less severe effects.

  • The study was published on April 15, 2026.
  • The research was conducted on mice.

The players

Saurabh Chatterjee

Professor of environmental & occupational health at the University of California, Irvine's Joe C. Wen School of Population & Public Health and the corresponding author of the study.

Punnag Saha

A former graduate student researcher in Chatterjee's lab and the first author of the study.

University of California, Irvine

The university where the research was conducted, a member of the prestigious Association of American Universities and ranked among the nation's top 10 public universities.

Gut Microbes

The journal in which the study was published.

Vibrio vulnificus

A potentially life-threatening foodborne bacterium commonly associated with seafood consumption that was used in the study.

Got photos? Submit your photos here. ›

What they’re saying

“Our findings show that underlying liver disease doesn't just increase infection risk – it fundamentally changes how the body responds.”

— Saurabh Chatterjee, Professor of environmental & occupational health

“These results suggest that the gut microbiome isn't just a bystander – it's a modifiable factor that could be targeted to reduce infection severity.”

— Punnag Saha, Former graduate student researcher

What’s next

The researchers plan to further investigate how specific gut microbiome alterations contribute to the increased severity of foodborne infections in MASLD patients, with the goal of developing targeted therapies and interventions to protect high-risk populations.

The takeaway

This study highlights the critical role of the gut-liver axis and gut microbiome dysfunction in driving worse outcomes for fatty liver disease patients facing foodborne infections. The findings open up new avenues for prevention, risk reduction, and microbiome-based treatments to better safeguard vulnerable populations as these types of illnesses continue to rise globally.